Diagnos Laboratorium Utama Tbk. vs Semacom Integrated Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Semacom Integrated Tbk. trades at Rp91 (market cap 122.6B, 2.1M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 2.5× Semacom Integrated Tbk.'s market cap, and Semacom Integrated Tbk. is more actively traded (2.1M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | SEMA | |
|---|---|---|
Market Cap | 310.75B | 122.6B |
Volume | 963.6K | 2.1M |
Lot | 9.64K | 20.99K |
Turnover | 217.67M | 195.18M |
Average Price | 225.89 | 92.98 |
Value | 217.67M | 195.18M |
Indicative Equilibrium Price | 226 | 91 |
Indicative Equilibrium Volume | 1K | 174 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Semacom Integrated Tbk (the Company) was established in the Republic of Indonesia on October 01, 2009 based on Notarial deed No. 5 of H. Dana Sasmita, S.H, Notary in Jakarta The Company begin opertions commercial activities since 2009.
Read more on SEMA →